Extracorporeal circulation without bleeding.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24500403.
- Also identified by DOI 10.1126/scitranslmed.3008497.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A newly created antibody to the active site of Factor XIIa protects against clotting of extracorporeal bypass circuitry without bleeding risk in vivo, obviating the need for heparin (Larsson et al., this issue).
Medical subject headings
- Extracorporeal Circulation
- Hemorrhage